P-selectin glycoprotein ligand-1 (psgl-1/cd162) is incorporated into clinical hiv-1 isolates and can mediate virus capture and subsequent transfer to permissive cells

HIGHLIGHTS

• who: Jonathan Burnie from the Department of Biological Sciences, University of Toronto Scarborough, Military Trail, Toronto, ON, Canada have published the article: P-selectin glycoprotein ligand-1 (PSGL-1/CD162) is incorporated into clinical HIV-1 isolates and can mediate virus capture and subsequent transfer to permissive cells, in the Journal: (JOURNAL)
• what: Unique to this study the authors show that PSGL-1 is incorporated in a broad range of HIV-1 and SIV isolates and that virions with incorporated PSGL-1 are detectable in plasma from viremic HIV-1-infected individuals corroborating the relevance . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.